Lv4
560 积分 2023-04-27 加入
Global landscape of PROTAC: Perspectives from patents, drug pipelines, clinical trials, and licensing transactions
3个月前
已完结
Discovery of KIN-8741, a Highly Selective Type IIb c-Met Kinase Inhibitor with Broad Mutation Coverage and Quality Drug-Like Properties for the Treatment of Cancer
3个月前
已完结
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
4个月前
已完结
Catalytic undirected borylation of tertiary C–H bonds in bicyclo[1.1.1]pentanes and bicyclo[2.1.1]hexanes
6个月前
已完结
Phenyl‐Glutarimides: Alternative Cereblon Binders for the Design of PROTACs
6个月前
已完结
Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target
9个月前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
10个月前
已完结
The targeted protein degradation landscape
11个月前
已完结
Elemental exchange: Bioisosteric replacement of phosphorus by boron in drug design
11个月前
已完结
Derivatization with fatty acids in peptide and protein drug discovery
1年前
已完结
皖公网安备34019202002308
